Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

46.12
Delayed Data
As of Sep 26
 -0.48 / -1.03%
Today’s Change
29.50
Today|||52-Week Range
59.41
-2.06%
Year-to-Date

Today’s Trading

Previous close46.60
Today’s open46.48
Day’s range46.04 - 46.92
Volume469,900
Average volume (3 months)385,911
Market cap$1.5B
Dividend yield--
Data as of 09/26/2016

Growth & Valuation

Earnings growth (last year)-2.76%
Earnings growth (this year)+9.76%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+15.67%
P/E ratio23.2
Price/Sales3.54
Price/Book4.77

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc-0.31-1.26%
HCMHutchison China Medi...-0.11-0.90%
AXONAxovant Sciences Ltd-0.57-3.73%
CLVSClovis Oncology Inc-0.32-0.86%
Data as of 09/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.41
Annual revenue (last year)$433.3M
Annual profit (last year)$57.2M
Net profit margin13.19%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts

Search for Jobs